Connect Biopharma Holdings Limited announced On November 17, 2023, the Board of Directors of company appointed Kan Chen, Ph.D., current member of the Board, to serve as a member the Compensation Committee of the Board. Dr Chen is filling a vacancy created upon the previously announced resignation of Derek DiRocco, Ph.D., former member of the Compensation Committee, from the Board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 USD | -2.26% | -4.95% | +46.61% |
Apr. 17 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
Apr. 17 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.61% | 97.53M | |
+10.05% | 114B | |
+12.83% | 107B | |
-5.65% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.32% | 17.51B | |
-39.36% | 17.17B | |
+6.58% | 14.14B | |
+34.94% | 12.2B |
- Stock Market
- Equities
- CNTB Stock
- News Connect Biopharma Holdings Limited
- Connect Biopharma Holdings Limited Appoints Kan Chen as Member of Compensation Committee